Home / Indicator library / Biotechnology and Medical Care / TLB (4127) overview
TLB (4127) stock overview
Valuation, financials, growth, ownership, events, dividends, models and adjusted prices for TLB, on one pageTLB (4127) snapshot, key figures
TLB (4127): where today sits in the past year
Current value against the 2025-07-31 to 2026-07-31 range, built from 62 frozen daily vintages.
Seven-dimension checkup for this ticker →
Valuation river
→Financial quality
→Revenue growth
→Ownership structure
→Events, last 90 days
→Yield river
→Valuation models
→Adjusted-price candles
→4127: common questions
What is 4127's P/E ratio?
4127 traded at a price-to-earnings ratio of 532.14x in the official-source snapshot dated 2026-08-03. That figure is frozen as a point-in-time vintage, so a backtest reading it sees only what was knowable that day.
What is 4127's dividend yield?
4127's cash dividend yield was 0.00% on 2026-08-03. Historical dividend policy and gap-fill records are available on the same page.
How fast is 4127's revenue growing?
4127 reported 41.4% year-on-year monthly revenue growth for 2026-06, from the official monthly revenue filing.
Is 4127's price / earnings high or low right now?
4127's price / earnings is 532.14x, which is above its one-year median of 490.00x and sits at the 84th percentile of the 70.94–592.86x range observed over the last 62 snapshot dates. Each of those dates is a frozen point-in-time vintage, so the range contains no restated or back-filled values.
Other Biotechnology and Medical Care tickers
160 Taiwan-listed tickers sit in this sector. See the full Biotechnology and Medical Care table.